Health Condition 1: M16- Osteoarthritis of hip Health Condition 2: M17- Osteoarthritis of knee Health Condition 3: S80-S89- Injuries to the knee and lower leg Health Condition 4: S70-S79- Injuries to the hip and thigh Health Condition 5: S90-S99- Injuries to the ankle and foot
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)Patient willing to sign the written informed consent. 2) Patients belonging to American Society of Anaesthesiologists (ASA) Grade I or II. 3) Male or female patients between age 18-60 years. 4) Patients undergoing elective lower limb orthopedic surgeries under spinal anesthesia.
Exclusion criteria
Exclusion criteria: 1) Patients unwilling to participate in the study. 2) Patients belonging to ASA Grade III or more. 3) Pregnant or lactating woman. 4) History of known allergy to study drug. 5) Patients having any vertebral anomalies. 6) Patients who needs supplementation of general anaesthesia. 7) Any contraindication to Epidural Anaesthesia (local site infection, coagulation disorder, raised intacranial pressure, hemodynamic instability, neurological disorders,). 8) Children less than 18 years 9) Adults more than 60 years.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| This observational study will help us to know between epidural nalbuphine and epidural tramadol which as adjuvant to 0.2% ropivacaine provides better postoperative analgesia with minimal side effects in patients undergoing lower limb orthopaedic surgeries.Timepoint: postoperatively,the study drug will be administered via epidural route when VAS more than equal to 4. * The VAS before administration of drug is considered as "Base Line". * VAS is noted immediately after administration of drug * VAS is noted at 1st, 2nd, 3rd, 4th and so on till 10th hour after the administration of the drug via epidural route. | — |
Secondary
| Measure | Time frame |
|---|---|
| to compare the hemodynamics of the two groupsTimepoint: Blood Pressure, Pulse rate & Oxygen Saturation will be measured 1) at the time of administration of the drug as Baseline. 2) at 15 mins 3) at 30 mins 4) at 1 hour 5) at 2 hour 6) at 3 hour 7) at 4 hour 8) at 5 hour 9) at 6 hour 10) at 7 hour 11) at 8 hour 12) at 9 hour 13) at 10 hour | — |
Countries
India
Contacts
Smt.Bhikiben Kanjibhai Shah Medical Institute and Research Centre